University of Connecticut Health Center geneticists have made a two-fold discovery in gene recoding that will significantly increase understanding of the information in genome sequences and could prove to be a knowledge expressway scientists need for unraveling nervous system disorders such as Parkinson Disease and epilepsy.
The research, published in the Aug. 8 issue of the journal Science, was supported by the National Science Foundation (NSF), the independent federal agency that supports fundamental research and education across all fields of science and engineering.
Geneticist Robert Reenan and fellow researchers used comparative genomics to discover a telltale signature of genes that are recoded as DNA is converted to RNA during the protein-making process. There, an enzyme converts adenosine to the nucleoside inosine by a process called "A-to-I" RNA editing. The scientists subsequently found that such recoding is largely confined to the nervous system across species and pinpointed a target of the process in humans.
"The proteins targeted by editing are basically the machinery that allow nervous systems to function on a timescale of milliseconds, which is not a demand placed on every organ," said Reenan.
The phylogenetic signatures are identical sequences of genetic coding found in each species studied, serving as markers corresponding to specific genes targeted for A-to-I RNA editing. The identical presence in both species suggests that the editing site arose some time ago evolutionarily and has been retained in these species -- and likely others -- because it provides a broadly useful selective advantage for survival.
Recoding, or "RNA editing," and the entire process are much like photocopying a recipe from a cookbook and writing changes on the photocopy rather than on the books pages. The revisions on the copy would then be used to prepare the food, but the original recipe in the book would remain unchanged.
For cells to manufacture protein, they must first copy the segment of the genes DNA that holds the blueprint or Scoding" for the protein. This copy, which consists of a single strand of RNA, is called messenger RNA, or "mRNA." Converting the DNA into the mRNA instructions that code for the manufacture of protein from amino acids is called "transcription." The working mRNA copy is sometimes modified, or "recoded," as it is formed. It is unknown how many RNA transcripts for genes are recoded in the human genome because this process occurs on the copies rather than the original.
For more than a decade, sites where A-to-I RNA editing had occurred were discovered largely by chance. "The one thing that becomes clear about the RNA editing sites is that theyre all different; there (was) no way to predict where an RNA editing site would occur from genome sequence," said Reenan. "We hoped to get clues about RNA editing by comparing genomes of different species."
Clues came as the researchers compared more than 900 genes between two species of the fruit fly Drosophila. They found a signature in genomic DNA in genes shared between species where RNA transcription products are destined to be edited by the enzyme adenosine deaminase. "The signature we found was an unexpectedly high level of DNA sequence identity between species," said Reenan. The signature reliably identifies genes that are recoded during transcription, providing scientists with a means to predict the occurrence of editing.
"Being able to predict editing sites is a revolutionary discovery that will greatly increase the value of existing genome sequences," said Molecular Biologist Joanne Tornow, a program director with the NSFs Division of Molecular and Cellular Biosciences. "Dr. Reenans use of comparative genomics to make this very significant finding underscores the importance of investing in the sequencing of a wide variety of organisms." Reenan and his colleagues then applied their newfound knowledge to a wide range of human, mouse and rat genes. They found the process also targets a gene in the human brain already known to foster an inherited form of epilepsy.
So far, the researchers have noticed A-to-I RNA editing in only nervous systems and specifically in genes encoding proteins necessary for sending fast electrical and chemical signals. They examined many genes not directly involved in nervous system function.
"The literal genome is not the final word and, for whatever reason, this mechanism (A-to-I editing) is almost exclusive to the nervous system," Reenan said.
With the knowledge of the signature and that A-to-I RNA editing occurs primarily in nervous systems, scientists can now more closely examine how recoding affects expression by nervous systemspecific genes, including those responsible for epilepsy and Parkinson Disease.
Principal Investigator: Robert Reenan, (+1-860) 679-3691, firstname.lastname@example.org
Manny Van Pelt | National Science Foundation
Generation of a Stable Biradical
22.03.2018 | Julius-Maximilians-Universität Würzburg
Make way for the mini flying machines
21.03.2018 | American Chemical Society
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
21.03.2018 | Physics and Astronomy
21.03.2018 | Materials Sciences
21.03.2018 | Life Sciences